Private Capital Advisors’s Ionis Pharmaceuticals IONS Stock Holding History

Private Capital Advisors’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-4,100	Closed	-$254K	–	106
2015 Q4	$254K	Sell	4,100 -31,750	-89%	-$1.71M	0.11%	102
2015 Q3	$1.45M	Buy	35,850 +750	+2%	+$38.8K	0.61%	51
2015 Q2	$2.02M	Sell	35,100 -71,220	-67%	-$4.53M	0.66%	55
2015 Q1	$6.77M	Buy	106,320 +74,720	+236%	+$5.07M	2.46%	5
2014 Q4	$1.95M	Buy	+31,600	New	+$1.56M	0.73%	54
2014 Q3	–	Sell	-13,700	Closed	-$472K	–	119
2014 Q2	$472K	Buy	+13,700	New	+$431K	0.15%	91

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Private Capital Advisors's IONS Position: Q1 2016 in Review

Private Capital Advisors sold out of Ionis Pharmaceuticals (IONS) in Q1 2016, closing a stake of 4,100 shares — an estimated $254K sold.

Private Capital Advisors first reported a position in IONS in Q2 2014 and held it in 6 quarters. The position peaked at $6.77M in Q1 2015. 315 funds tracked by Wall St. Rank hold IONS as of Q1 2016.

Private Capital Advisors reported no remaining Ionis Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
Private Capital Advisors sold 4,100 Ionis Pharmaceuticals shares in Q1 2016, an estimated $254K.
Private Capital Advisors first reported a position in Ionis Pharmaceuticals in Q2 2014 and held it in 6 quarters.
Private Capital Advisors's Ionis Pharmaceuticals position peaked at $6.77M in Q1 2015.
315 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2016.

Based on Private Capital Advisors's 13F filing for Q1 2016, filed 26 Apr 2016.